Allurion Technologies (ALURD) Common Equity (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Common Equity came in at -$77.9 million in Q1 2026, down 11.63% YoY from -$88.2 million in Q1 2025, and down 0.93% on a QoQ basis from -$77.2 million in Q4 2025.
Allurion Technologies (ALURD) Common Equity (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Common Equity data on file, last reported at -$77.9 million in Q1 2026.
- Quarterly Common Equity fell 11.63% year-over-year to -$77.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$77.9 million (down 11.63% YoY) and the FY2025 annual result came in at -$77.2 million, up 1.01% from the prior year.
- Common Equity eased to -$77.9 million in Q1 2026, from -$77.2 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of -$6.7 million in Q2 2022 to a low of -$82.9 million in Q3 2025.
- A 5-year average of -$59.7 million and a median of -$68.0 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2023 — Common Equity slumped 962.0% — and 2025, when it increased 9.36%.
- Tracing ALURD's Common Equity over 5 years: stood at -$32.3 million in 2022, then tumbled by 120.64% to -$71.3 million in 2023, then dropped by 9.37% to -$78.0 million in 2024, then gained by 1.01% to -$77.2 million in 2025, then retreated by 0.93% to -$77.9 million in 2026.
- The last three Common Equity figures came in at -$77.9 million (Q1 2026), -$77.2 million (Q4 2025), and -$82.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | -77.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.91 Mn |
| Dec 31, 2025 | -77.19 Mn |
| Sep 30, 2025 | -82.93 Mn |
| Jun 30, 2025 | -63.98 Mn |
| Mar 31, 2025 | -69.79 Mn |
| Dec 31, 2024 | -77.98 Mn |
| Sep 30, 2024 | -64.79 Mn |
| Jun 30, 2024 | -70.58 Mn |
| Mar 31, 2024 | -66.16 Mn |
| Dec 31, 2023 | -71.30 Mn |
| Sep 30, 2023 | -52.76 Mn |
| Jun 30, 2023 | -71.22 Mn |
| Mar 31, 2023 | -49.66 Mn |
| Dec 31, 2022 | -32.31 Mn |
| Sep 30, 2022 | -20.17 Mn |
| Jun 30, 2022 | -6.71 Mn |